Comprehensive approach to management of critical limb ischemia.

Lanfroi Graziani
Author Information
  1. Lanfroi Graziani: Istituto Clinico Città di Brescia Hospital, Brescia, Italy, langrazi@tin.it.

Abstract

OPINION STATEMENT: Fighting major amputation has been one out of the four priorities of the World Health Organization (WHO) for a decade. If we consider that according to all epidemiological studies, the number of diabetic people is expected to double by 2030, the worse complication of this disease could represent a big sanitary, social, and economic problem in the near future. In developed countries, the cost of treatment for diabetic disease-related foot problems represents 15 - 25 % of available resources for the treatment of diabetes in general, but in some developing countries, the same cost may reach up to 40 % of available resources for diabetic disease. On the positive side, currently over 90 % of all diabetes-related amputations may be prevented thanks to the education of diabetic patients as primary prevention, and mainly to the new non-surgical revascularization techniques, which effectively fight the consequences of diabetic arteriopathy as a secondary prevention. The virtual pathway in reducing lower limb amputations starts with a better comprehension of critical limb ischemia (CLI), particularly its diagnostic aspects and consequent revascularization treatment. For 15 years we have assisted in a spectacular improvement of revascularization modalities and particularly of endovascular interventions. As a consequence, a large series of treated patients have shown the possibility to reduce the risk of limb loss in subjects at a higher risk to a rate of 1.7 - 2.4 %. Management of CLI requires integrating clinical, interventional, and surgical competencies together to a significant cultural advancement of every single physician involved in reducing the risk of limb loss. Consensus documents and international guidelines are, in general, precious opportunities to promote cultural and scientific upgrading of the involved specialist, but their results sometimes do not meet the physician's expectations. A close look into the available scientific literature adopted for scientific statements reveals an urgent need for standardized reporting of demographic data, severity of disease, and outcome of the studied population.

References

  1. J Vasc Surg. 1998 Dec;28(6):976-80; discussion 981-3 [PMID: 9845648]
  2. Diabet Med. 2007 Aug;24(8):823-9 [PMID: 17559430]
  3. Eur J Vasc Endovasc Surg. 2002 Oct;24(4):309-13 [PMID: 12323173]
  4. Int J Clin Pract. 2009 Jun;63(6):855-8 [PMID: 18248395]
  5. Eur J Vasc Endovasc Surg. 2008 Jul;36(1):90-5 [PMID: 18356086]
  6. J Vasc Surg. 1995 Mar;21(3):375-84 [PMID: 7877219]
  7. Vasc Endovascular Surg. 2002 May-Jun;36(3):207-12 [PMID: 12075386]
  8. J Vasc Surg. 2008 Jul;48(1):137-43 [PMID: 18502081]
  9. J Vasc Surg. 2002 Jan;35(1):48-54; discussion, 54-5 [PMID: 11802132]
  10. Diabetes Care. 1994 Sep;17(9):983-7 [PMID: 7988319]
  11. J Vasc Surg. 2009 Jul;50(1):54-60 [PMID: 19481407]
  12. J Intern Med. 2002 Sep;252(3):225-32 [PMID: 12270002]
  13. Eur J Vasc Endovasc Surg. 2007;33 Suppl 1:S1-75 [PMID: 17140820]
  14. Vasa. 2010 Feb;39(1):67-75 [PMID: 20186678]
  15. Circulation. 2001 Oct 23;104(17):2057-62 [PMID: 11673346]
  16. Cardiovasc Res. 2001 Feb 16;49(3):554-60 [PMID: 11166268]
  17. J Am Coll Cardiol. 2009 Sep 8;54(11):989-96 [PMID: 19729114]
  18. Ann Vasc Surg. 2002 Sep;16(5):601-7 [PMID: 12183777]
  19. Surg Clin North Am. 2008 Dec;88(6):1295-313, ix [PMID: 18992596]
  20. N Engl J Med. 2004 Dec 30;351(27):2795-804 [PMID: 15625331]
  21. Diabet Med. 2005 Apr;22(4):460-5 [PMID: 15787673]
  22. J Vasc Surg. 2007 May;45(5):944-52 [PMID: 17391900]
  23. Diabetes Care. 2001 Jan;24(1):78-83 [PMID: 11194246]
  24. J Vasc Surg. 1987 Nov;6(5):454-9 [PMID: 3669195]
  25. Am J Surg. 1994 Dec;168(6):646-50; discussion 650-1 [PMID: 7978012]
  26. Eur J Vasc Endovasc Surg. 2007 Jun;33(6):731-6 [PMID: 17296318]
  27. Circulation. 2006 Aug 15;114(7):688-99 [PMID: 16908785]
  28. J Vasc Surg. 2008 May;47(5):975-981 [PMID: 18372148]
  29. Cardiovasc Intervent Radiol. 2003 May-Jun;26(3):251-5 [PMID: 14562973]
  30. J Diabetes Complications. 1998 Mar-Apr;12(2):96-102 [PMID: 9559487]
  31. J Vasc Surg. 1995 Jan;21(1):35-44; discussion 44-5 [PMID: 7823360]
  32. J Vasc Surg. 2013 Jan;57(1):242-53 [PMID: 23159476]
  33. J Vasc Surg. 1992 Jun;15(6):982-8; discussion 989-90 [PMID: 1597896]
  34. Diabetes. 2008 Oct;57(10):2818-23 [PMID: 18633114]
  35. Ann Vasc Surg. 2009 May-Jun;23(3):367-73 [PMID: 19179041]
  36. Vasa. 2006 Feb;35(1):15-20 [PMID: 16535964]
  37. J Vasc Surg. 2003 Nov;38(5):1056-9 [PMID: 14603217]
  38. Plast Reconstr Surg. 1998 Sep;102(3):599-616; discussion 617-8 [PMID: 9727424]
  39. Eur J Vasc Endovasc Surg. 2009 Mar;37(3):336-42 [PMID: 19112033]
  40. Vasc Endovascular Surg. 2006 Aug-Sep;40(4):303-11 [PMID: 16959724]
  41. J Vasc Surg. 1995 Sep;22(3):280-5; discussion 285-6 [PMID: 7674471]
  42. Cardiovasc Intervent Radiol. 2006 Jan-Feb;29(1):29-38 [PMID: 16252079]
  43. J Vasc Surg. 2001 May;33(5):955-62 [PMID: 11331834]
  44. J Vasc Surg. 1993 Jun;17(6):1029-38; discussion 1038-40 [PMID: 8505781]
  45. Ann Vasc Surg. 2000 Nov;14(6):640-7 [PMID: 11128460]
  46. J Vasc Surg. 2004 Dec;40(6):1149-57 [PMID: 15622369]
  47. Diabetes Care. 2009 May;32(5):822-7 [PMID: 19223609]
  48. Circulation. 1999 Nov 23;100(21):2168-76 [PMID: 10571976]
  49. Eur J Vasc Endovasc Surg. 2007 Apr;33(4):453-60 [PMID: 17196848]
  50. J Endovasc Ther. 2006 Feb;13(1):12-22 [PMID: 16445317]
  51. Rozhl Chir. 2003 Oct;82(10):516-21 [PMID: 14661354]
  52. J Vasc Surg. 2003 Feb;37(2):307-15 [PMID: 12563200]
  53. Lancet. 2005 Dec 3;366(9501):1925-34 [PMID: 16325694]
  54. MMWR Morb Mortal Wkly Rep. 1998 Aug 14;47(31):649-52 [PMID: 9716396]
  55. Cardiovasc Intervent Radiol. 1996 Sep-Oct;19(5):317-22 [PMID: 8781151]
  56. Eur J Surg. 2000 Feb;166(2):123-8 [PMID: 10724489]
  57. Diabetes Care. 2010 May;33(5):977-82 [PMID: 20200304]
  58. Ann Vasc Surg. 2009 Sep-Oct;23(5):554-9 [PMID: 19632085]
  59. Eur J Vasc Surg. 1991 Jun;5(3):265-9 [PMID: 1864392]
  60. J Vasc Surg. 2001 Jan;33(1):6-16 [PMID: 11137918]
  61. J Vasc Surg. 1997 Sep;26(3):517-38 [PMID: 9308598]
  62. Ann Surg. 1993 Jun;217(6):699-708; discussion 708-10 [PMID: 8507116]
  63. J Vasc Surg. 2007 Aug;46(2):271-279 [PMID: 17600656]
  64. J Endovasc Ther. 2008 Jun;15(3):363-9 [PMID: 18540709]
  65. J Vasc Surg. 2002 Nov;36(5):969-74 [PMID: 12422107]
  66. Cardiovasc Intervent Radiol. 2008 Jul-Aug;31(4):713-22 [PMID: 18509701]
  67. Ann Vasc Surg. 2001 Mar;15(2):175-81 [PMID: 11265081]
  68. N Engl J Med. 2009 Mar 5;360(10):961-72 [PMID: 19228612]
  69. ANZ J Surg. 2004 Mar;74(3):129-33 [PMID: 14996159]
  70. Catheter Cardiovasc Interv. 2010 Feb 15;75(3):433-43 [PMID: 19937784]
  71. J Vasc Surg. 2008 Aug;48(2):382-8 [PMID: 18572360]
  72. J Endovasc Ther. 2002 Aug;9(4):403-10 [PMID: 12222999]
  73. Eur J Vasc Endovasc Surg. 2005 Jun;29(6):620-7 [PMID: 15878541]
  74. Am J Cardiol. 2001 Nov 1;88(9):1057-60 [PMID: 11704013]
  75. J Vasc Interv Radiol. 2000 Sep;11(8):1021-31 [PMID: 10997465]
  76. N Engl J Med. 1984 Dec 20;311(25):1615-9 [PMID: 6390204]
  77. Diabetes Metab Res Rev. 2012 Feb;28 Suppl 1:179-217 [PMID: 22271740]
  78. Ann Vasc Surg. 1997 Sep;11(5):505-9 [PMID: 9302063]
  79. J Vasc Interv Radiol. 2002 May;13(5):455-63 [PMID: 11997353]
  80. Ann Acad Med Singap. 2008 Mar;37(3):224-9 [PMID: 18392302]
  81. Eur J Vasc Surg. 1993 Jul;7(4):409-13 [PMID: 8359297]
  82. Int Angiol. 1996 Jun;15(2):138-43 [PMID: 8803638]
  83. Eur J Vasc Endovasc Surg. 2009 Apr;37(4):448-56 [PMID: 19213580]
  84. Diabetes Care. 2008 May;31(5):887-92 [PMID: 18268064]
  85. EuroIntervention. 2005 Aug;1(2):219-27 [PMID: 19758907]
  86. Vasa. 2000 Aug;29(3):207-14 [PMID: 11037720]

Word Cloud

Created with Highcharts 10.0.0diabeticlimbdiseasetreatmentavailablerevascularizationriskscientificcountriescost-resourcesgeneralmayamputationspatientspreventionreducingcriticalischemiaCLIparticularlylossculturalinvolvedOPINIONSTATEMENT:FightingmajoramputationonefourprioritiesWorldHealthOrganizationWHOdecadeconsideraccordingepidemiologicalstudiesnumberpeopleexpecteddouble2030worsecomplicationrepresentbigsanitarysocialeconomicproblemnearfuturedevelopeddisease-relatedfootproblemsrepresents1525 %diabetesdevelopingreach40 %positivesidecurrently90 %diabetes-relatedpreventedthankseducationprimarymainlynewnon-surgicaltechniqueseffectivelyfightconsequencesarteriopathysecondaryvirtualpathwaylowerstartsbettercomprehensiondiagnosticaspectsconsequent15 yearsassistedspectacularimprovementmodalitiesendovascularinterventionsconsequencelargeseriestreatedshownpossibilityreducesubjectshigherrate1724 %ManagementrequiresintegratingclinicalinterventionalsurgicalcompetenciestogethersignificantadvancementeverysinglephysicianConsensusdocumentsinternationalguidelinespreciousopportunitiespromoteupgradingspecialistresultssometimesmeetphysician'sexpectationscloselookliteratureadoptedstatementsrevealsurgentneedstandardizedreportingdemographicdataseverityoutcomestudiedpopulationComprehensiveapproachmanagement

Similar Articles

Cited By